V.SBM
|
R + F should target their customers that previously ordered HydroQ with a...
|
V.SBM
|
& placing buy orders may help retain shares and slow the bleeding...
|
V.SBM
|
Raising awareness could include those that read this to order their own tube...
|
V.SBM
|
That Price Target at that time turns out to be accurate, taking into account...
|
V.SBM
|
Could be a SGLT2/Metformin or SGLT2/DPP4i combination tablet
|
V.SBM
|
When at least 3 near term runnups are expected and a new product, promoted by...
|
V.SBM
|
That has always been the trend it seems, sell on rumour, buy back 3 days post...
|
V.SBM
|
That has always been the trend it seems, sell on rumour, buy back 3 days post...
|
V.SBM
|
In the NR, Howie said he was going to do everything exactly the same for all...
|
V.KNE
|
Volumes spiked recently. I saw this pattern back with Kane was at .08...
|
V.SBM
|
Insti's and Funds seldom allow their money managers to touch a stock...
|
V.SBM
|
Yes and the trading pattern before and after an expected NR is fairly...
|
V.SBM
|
There were at least 9 x 500 asks on my filled bid at .45, followed by a bunch...
|
V.KNE
|
All the wheels of this company are turning, the management group is solid...
|
V.SBM
|
Appears the R+F NR was baked into the share price during the runnup. Revenue...
|
V.SBM
|
iscfa: this is from Sirona's NR Feb 13, 2019, " As part of...
|
V.SBM
|
Their new targeted dark spot corrector cited this study, "2Based on an...
|
V.SBM
|
The Volumes suugest its a massive amount of apples falling from the tree...
|
V.SBM
|
I remember Anonymous selling at .09 few years back..
|
V.SBM
|
If nothing is announced this week, the loss in Market Cap will be enormous...
|